SHL Medical, a Swiss provider of self-injection solutions, announced on Thursday that it is planning to establish SHL Advantec, a sub-group dedicated to providing tooling and automation solutions to the healthcare sector and other industries.
SHL Advantec will be headquartered in Zug, Switzerland and will commence operations with more than 600 employees across its offices and production sites in Switzerland, China, Taiwan, Mexico and the United States.
SHL Medical's existing tooling and automation operations will be integrated into SHL Advantec, bringing its range of technologies, services and equipment portfolio to the new business. Together with SHL Medical's recent strategic acquisitions -- Swiss-based LCA Automation and SMC Mould Innovation and US-based Superior Tooling -- SHL Advantec will form a global operations network spanning three continents to deliver faster support and shorter supply chain services to SHL Advantec's diverse customer base. Leveraging its experience in medical devices and other industries, SHL Advantec says that it will focus on helping its customers advance production quality and resilience while continuing to support SHL Medical's growth in autoinjector manufacturing.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system